Savage, Sharon A.
National Cancer Institute · Division of Cancer Epidemiology and Genetics
21 papers on CoChatORCID 0000-0001-6006-0740
Most cited papers
- Verified
Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer
Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments
Cited by 2,199
- Verified
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · International Journal of Cancer
Sarcoma Diagnosis and TreatmentGlobal Cancer Incidence and Screening
Cited by 791
- Verified
Detectable clonal mosaicism and its relationship to aging and cancer
Jacobs, K. B., Yeager, M., Zhou, W., Wacholder, S., Wang, Z., Rodriguez-Santiago, B., Hutchinson, A., Deng, X., Liu, C., Horner, M.-J., et al. (2012) · Nature Genetics
Cancer Genomics and DiagnosticsGenomic variations and chromosomal abnormalities
Cited by 589
- Verified
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research
Cancer-related Molecular PathwaysMultiple and Secondary Primary Cancers
Cited by 534
- Verified
Cancer in dyskeratosis congenita
Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2009) · Blood
Blood disorders and treatmentsTelomeres, Telomerase, and Senescence
Cited by 478
- Verified
The association of telomere length and cancer: a meta-analysis
Wentzensen, I. M., Mirabello, L., Pfeiffer, R. M., & Savage, S. A. (2011) · Cancer Epidemiology, Biomarkers & Prevention
Telomeres, Telomerase, and SenescenceGenetic Associations and Epidemiology
Cited by 458
- Verified
TINF2, a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenita
Savage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics
Telomeres, Telomerase, and SenescenceBlood disorders and treatments
Cited by 414
- Verified
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita
Alter, B. P., Baerlocher, G. M., Savage, S. A., Chanock, S. J., Weksler, B. B., Willner, J. P., Peters, J. A., Giri, N., & Lansdorp, P. M. (2007) · Blood
Telomeres, Telomerase, and SenescenceBlood disorders and treatments
Cited by 356
- Verified
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
NCI DCEG Cancer Sequencing Working Group, Shi, J., Laboratory, N. D. C. G. R., French Familial Melanoma Study Group, Yang, X. R., Ballew, B., Rotunno, M., Calista, D., Fargnoli, M. C., Ghiorzo, P., et al. (2014) · Nature Genetics
Cutaneous Melanoma Detection and ManagementTelomeres, Telomerase, and Senescence
Cited by 331
- Verified
Dyskeratosis Congenita
Savage, S. A., & Alter, B. P. (2009) · Hematology/Oncology Clinics of North America
Blood disorders and treatmentsTelomeres, Telomerase, and Senescence
Cited by 262
- Verified
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita
Zhong, F., Savage, S. A., Shkreli, M., Giri, N., Jessop, L., Myers, T., Chen, R., Alter, B. P., & Artandi, S. E. (2011) · Genes & Development
Telomeres, Telomerase, and SenescenceNuclear Structure and Function
Cited by 262
- Verified
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma
Mirabello, L., Zhu, B., Koster, R., Karlins, E., Dean, M., Yeager, M., Gianferante, M., Spector, L. G., Morton, L. M., Karyadi, D., et al. (2020) · JAMA Oncology
Sarcoma Diagnosis and TreatmentBRCA gene mutations in cancer
Cited by 243
- Verified
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita
Alter, B. P., Rosenberg, P. S., Giri, N., Baerlocher, G. M., Lansdorp, P. M., & Savage, S. A. (2012) · Haematologica
Telomeres, Telomerase, and SenescenceBlood disorders and treatments
Cited by 238
- Verified
Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma
Khanna, C., Fan, T. M., Gorlick, R., Helman, L. J., Kleinerman, E. S., Adamson, P. C., Houghton, P. J., Tap, W. D., Welch, D. R., Steeg, P. S., et al. (2014) · Clinical Cancer Research
Sarcoma Diagnosis and TreatmentCancer Cells and Metastasis
Cited by 178
- Verified
Germline TP53 Variants and Susceptibility to Osteosarcoma
Mirabello, L., Yeager, M., Mai, P. L., Gastier-Foster, J. M., Gorlick, R., Khanna, C., Patiño-Garcia, A., Sierrasesúmaga, L., Lecanda, F., Andrulis, I. L., et al. (2015) · JNCI Journal of the National Cancer Institute
Sarcoma Diagnosis and TreatmentCancer-related Molecular Pathways
Cited by 155
- Verified
Beginning at the ends: telomeres and human disease
Savage, S. A. (2018) · F1000Research
Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms
Cited by 124
- Verified
Height at diagnosis and birth-weight as risk factors for osteosarcoma
Mirabello, L., Pfeiffer, R., Murphy, G., Daw, N. C., Patiño-Garcia, A., Troisi, R. J., Hoover, R. N., Douglass, C., Schüz, J., Craft, A. W., et al. (2011) · Cancer Causes & Control
Sarcoma Diagnosis and TreatmentCancer Risks and Factors
Cited by 116
- Verified
Association Between Donor Leukocyte Telomere Length and Survival After Unrelated Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia
Gadalla, S. M., Wang, T., Haagenson, M., Spellman, S. R., Lee, S. J., Williams, K. M., Wong, J. Y., De Vivo, I., & Savage, S. A. (2015) · JAMA
Hematopoietic Stem Cell TransplantationTelomeres, Telomerase, and Senescence
Cited by 95
- Verified
Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia
Savage, S. A., Calado, R. T., Xin, Z.-T., Ly, H., Young, N. S., & Chanock, S. J. (2006) · Experimental Hematology
Telomeres, Telomerase, and SenescenceBlood disorders and treatments
Cited by 47
- Verified
Defining the complex needs of families with rare diseases—the example of telomere biology disorders
Wilsnack, C., Rising, C. J., Pearce, E. E., Forbes Shepherd, R., Thompson, A. S., Majid, A., Werner-Lin, A., Savage, S. A., & Hutson, S. P. (2024) · European Journal of Human Genetics
Genomics and Rare DiseasesFamily and Disability Support Research
Cited by 7
- Verified
“Crying in the Wilderness”—The Use of Web-Based Support in Telomere Biology Disorders: Thematic Analysis
Pearce, E. E., Majid, A., Brown, T., Shepherd, R. F., Rising, C., Wilsnack, C., Thompson, A. S., Gilkey, M. B., Ribisl, K. M., Lazard, A. J., et al. (2024) · JMIR Formative Research
Health Literacy and Information AccessibilitySocial Media in Health Education
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free